Mohammad Mahmoud, MD, MS, reviews important updates in metastatic prostate cancer presented at AUA 2025, including promising results from a novel BMS androgen receptor antagonist and degrader in ...
Mohammad Mahmoud, MD, looks ahead to the 2025 American Urological Association (AUA) meeting in Las Vegas, which will feature a robust program on metastatic prostate cancer centering on new research, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback